SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-005901
Filing Date
2020-08-13
Accepted
2020-08-13 08:30:25
Documents
56
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_081320p.htm 10-Q 561407
2 EXHIBIT 23.1 exh_231.htm EX-23.1 4275
3 EXHIBIT 31.1 exh_311.htm EX-31.1 7301
4 EXHIBIT 31.2 exh_312.htm EX-31.2 7362
5 EXHIBIT 32.1 exh_321.htm EX-32.1 4690
6 EXHIBIT 32.2 exh_322.htm EX-32.2 4776
  Complete submission text file 0001171843-20-005901.txt   2881938

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE acst-20200630.xml EX-101.INS 461276
8 XBRL SCHEMA FILE acst-20200630.xsd EX-101.SCH 38944
9 XBRL CALCULATION FILE acst-20200630_cal.xml EX-101.CAL 26101
10 XBRL DEFINITION FILE acst-20200630_def.xml EX-101.DEF 243871
11 XBRL LABEL FILE acst-20200630_lab.xml EX-101.LAB 197555
12 XBRL PRESENTATION FILE acst-20200630_pre.xml EX-101.PRE 263884
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35776 | Film No.: 201097355
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences